financetom
Business
financetom
/
Business
/
Klarna inches closer to hotly anticipated US debut after $1.37 billion IPO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Klarna inches closer to hotly anticipated US debut after $1.37 billion IPO
Sep 10, 2025 7:34 AM

By Arasu Kannagi Basil and Pritam Biswas

Sept 10 (Reuters) - Swedish fintech Klarna ( KLAR ) will begin

trading on the New York Stock Exchange later on Wednesday after

raising $1.37 billion in its initial public offering, ending a

years-long wait for a listing and reinforcing a rebound in the

U.S. IPO market.

The buy-now, pay-later (BNPL) lender is leading a slate of

seven companies, including Winklevoss twins' crypto exchange

Gemini, poised to go public in New York by Friday, in what is

set to be the U.S. IPO market's biggest week in years.

The strong lineup sets the stage for an eventful fall window

after tariff-driven volatility earlier in the year had slammed

brakes on a revival of new issues following a near three-year

dry spell.

Klarna ( KLAR ) and several other big names had halted their IPO

plans in April after tariff-driven volatility roiled stock

markets.

On Tuesday, Klarna ( KLAR ) and some of its investors sold 34.3

million shares at $40 each, above the marketed range of between

$35 and $37. The IPO valued Klarna ( KLAR ) at $15.1 billion.

"This (going public) is really an opportunity...primarily for

new shareholders, our 111 million consumers and others to really

partake in that journey to disrupt the financial services

industry and be the next generation of personal finance," Klarna ( KLAR )

Chief Financial Officer Niclas Neglén told Reuters in an

interview.

Selling shareholders, including Silicon Valley venture

capital giant Sequoia Capital and Danish billionaire Anders

Holch Povlsen's Heartland A/S, raised $1.17 billion in the IPO.

CEO Sebastian Siemiatkowski, who owns about 7% of

Klarna ( KLAR ), did not sell any shares in the IPO.

Klarna ( KLAR ) is the largest Swedish company to list its shares in

the U.S. since Spotify ( SPOT ) in 2018.

"$15 billion is far from disappointing given it was above

Klarna's ( KLAR ) price range and shows a continuing trend of issuers

being conservative in initial valuation expectations to garner

investor demand and to hopefully leave them wanting more," said

Samuel Kerr, head of equity capital markets at Mergermarket.

At its peak in 2021, Klarna ( KLAR ) raised funds at a $45.6 billion

valuation, which slumped to $6.7 billion a year later amid

rising inflation and higher interest rates.

The company had eyed a New York flotation for years, having

considered a direct listing - a route that avoids selling new

shares and the costs of a traditional IPO - in 2021.

BNPL IN FOCUS

Klarna ( KLAR ), founded in 2005 when e-commerce was nascent, has

since developed into a BNPL heavyweight, helping reshape online

shopping with its short-term financing model.

BNPL allows shoppers to pay for products in small

installments over time and has gained more popularity since the

COVID-19 pandemic.

The business is gaining momentum as customers navigate

sticky inflation, labor market cracks, and slowing income

growth.

"Klarna's ( KLAR ) IPO will be a thermometer, showing how hot, or

not, investors think BNPL will be," Brian Jacobsen, chief

economist at Annex Wealth Management said.

U.S.-based rival Affirm commands a $29 billion

market valuation and its shares have surged 45% this year. Its

latest quarterly report showed an average order value of $276,

compared with Klarna's ( KLAR ) $101 for the year ended June 30,

according to its IPO filing.

While Klarna ( KLAR ) primarily targets smaller purchases and

short-term loans, Affirm has focused on big-ticket purchases

with longer zero-interest financing.

Profitable for the first 14 years, Klarna ( KLAR ) has grappled with

losses in recent years as it expanded in the U.S. and other

markets.

BNPL will steadily grab market share from debit cards in

coming years, analysts have estimated, as shoppers increasingly

embrace the flexibility to spread payments over time.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved